• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响多名家庭成员的乳头状甲状腺癌:一例家族性非髓样甲状腺癌病例报告及文献综述

Papillary Thyroid Cancer Affecting Multiple Family Members: A Case Report and Literature Review of Familial Nonmedullary Thyroid Cancer.

作者信息

Baagar Khaled Ahmed, Alowainati Buthina Ibrahim

机构信息

Endocrine Department, Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.

出版信息

Case Rep Endocrinol. 2021 Oct 15;2021:3472000. doi: 10.1155/2021/3472000. eCollection 2021.

DOI:10.1155/2021/3472000
PMID:34691791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8536453/
Abstract

Familial nonmedullary thyroid cancer (FNMTC) represents 5-10% of NMTC cases. Many controversies are associated with the FNMTC, namely, the minimum required number of affected family members to define the condition, aggressiveness, prognosis, and treatment and screening recommendations. Moreover, the genetic basis of the FNMTC has not yet been identified. We report a family diagnosed with FNMTC and present a comprehensive literature review of the condition. The index case was a 26-year-old male who was diagnosed with locally advanced papillary thyroid cancer (PTC). Then, his family members became worried and asked for a neck ultrasound. Four of his six siblings, in addition to his father, were diagnosed with PTC. In addition, two of his cousins were diagnosed. The patient underwent total thyroidectomy with bilateral neck dissection, and he received 2 doses of radioactive iodine (100 mCi each). Furthermore, one of his siblings required a second surgery with repeated radioactive iodine therapy. The index case genetic screening and whole-exome sequencing did not show any abnormalities. Future genetic and clinical research should focus on kindred with 3 or more affected individuals for better identification of the FNMTC susceptibility genes and to better guide management and screening recommendations.

摘要

家族性非髓样甲状腺癌(FNMTC)占非髓样甲状腺癌(NMTC)病例的5%-10%。FNMTC存在许多争议,即定义该病所需的受影响家庭成员的最少数量、侵袭性、预后以及治疗和筛查建议。此外,FNMTC的遗传基础尚未确定。我们报告了一个被诊断为FNMTC的家族,并对该病进行了全面的文献综述。索引病例是一名26岁男性,被诊断为局部晚期乳头状甲状腺癌(PTC)。随后,他的家人感到担忧并要求进行颈部超声检查。他的六个兄弟姐妹中有四个,连同他的父亲,被诊断为PTC。此外,他的两个堂兄弟也被诊断出患有该病。该患者接受了全甲状腺切除术及双侧颈部清扫术,并接受了2剂放射性碘治疗(每次100 mCi)。此外,他的一个兄弟姐妹需要再次手术并重复进行放射性碘治疗。索引病例的基因筛查和全外显子测序未显示任何异常。未来的基因和临床研究应聚焦于有3个或更多受影响个体的家族,以更好地识别FNMTC易感基因,并更好地指导管理和筛查建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380f/8536453/b88104cb58ae/CRIE2021-3472000.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380f/8536453/b88104cb58ae/CRIE2021-3472000.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380f/8536453/b88104cb58ae/CRIE2021-3472000.001.jpg

相似文献

1
Papillary Thyroid Cancer Affecting Multiple Family Members: A Case Report and Literature Review of Familial Nonmedullary Thyroid Cancer.影响多名家庭成员的乳头状甲状腺癌:一例家族性非髓样甲状腺癌病例报告及文献综述
Case Rep Endocrinol. 2021 Oct 15;2021:3472000. doi: 10.1155/2021/3472000. eCollection 2021.
2
An update on familial nonmedullary thyroid cancer.家族性非髓样甲状腺癌的最新进展。
Endocrine. 2020 Jun;68(3):502-507. doi: 10.1007/s12020-020-02250-3. Epub 2020 Mar 11.
3
In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.在滤泡细胞来源的甲状腺癌患者中,一级亲属中有非髓样甲状腺癌家族史与更具侵袭性的疾病相关。
Thyroid. 2012 Jan;22(1):3-8. doi: 10.1089/thy.2011.0192. Epub 2011 Dec 2.
4
An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.家族性非髓样甲状腺癌的循证医学方法:筛查、临床管理及随访
World J Surg. 2007 May;31(5):924-33. doi: 10.1007/s00268-006-0847-1.
5
Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.家族性与散发性非髓样甲状腺癌的患病率、临床病理特征和体细胞基因突变谱。
Thyroid. 2011 Apr;21(4):367-71. doi: 10.1089/thy.2010.0256. Epub 2010 Dec 29.
6
CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function.家族性非髓样甲状腺癌中鉴定出的 CHEK2 种系变异导致蛋白结构和功能受损。
J Biol Chem. 2024 Mar;300(3):105767. doi: 10.1016/j.jbc.2024.105767. Epub 2024 Feb 16.
7
Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer.鉴定与家族性非髓样甲状腺癌发病机制相关的易感性基因突变。
Mol Genet Genomic Med. 2019 Dec;7(12):e1015. doi: 10.1002/mgg3.1015. Epub 2019 Oct 22.
8
Familial nonmedullary thyroid cancer: a review of the genetics.家族性非髓样甲状腺癌:遗传学综述。
Thyroid. 2010 Jul;20(7):795-801. doi: 10.1089/thy.2009.0216.
9
A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.一个患有家族性甲状腺乳头状癌滤泡变体的希腊家族:排除TCO、MNG1、fPTC/PRN和NMTC1作为易感基因座。
Thyroid. 2005 Dec;15(12):1349-54. doi: 10.1089/thy.2005.15.1349.
10
Familial nonmedullary thyroid carcinoma.家族性非髓样甲状腺癌
Cancer Control. 2006 Apr;13(2):106-10. doi: 10.1177/107327480601300204.

引用本文的文献

1
High expression of the gene promotes immune infiltration and improves tumor prognosis in ovarian serous carcinoma using bioinformatics analyses.利用生物信息学分析表明,该基因的高表达促进免疫浸润并改善卵巢浆液性癌的肿瘤预后。
Ann Transl Med. 2022 Oct;10(19):1055. doi: 10.21037/atm-22-3726.

本文引用的文献

1
Familial non-medullary thyroid cancer: a critical review.家族性非髓样甲状腺癌:批判性综述。
J Endocrinol Invest. 2021 May;44(5):943-950. doi: 10.1007/s40618-020-01435-x. Epub 2020 Oct 6.
2
Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?家族性非髓样甲状腺癌患者应行甲状腺全切除术吗?
World J Surg. 2020 Sep;44(9):3022-3027. doi: 10.1007/s00268-020-05473-7.
3
A Germline Mutation in the Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer.该基因中的种系突变是家族性非髓样甲状腺癌的一个候选因素。
Cancers (Basel). 2020 Jun 1;12(6):1441. doi: 10.3390/cancers12061441.
4
An update on familial nonmedullary thyroid cancer.家族性非髓样甲状腺癌的最新进展。
Endocrine. 2020 Jun;68(3):502-507. doi: 10.1007/s12020-020-02250-3. Epub 2020 Mar 11.
5
Germline Mutations in Familial Papillary Thyroid Cancer.家族性甲状腺乳头状癌中的种系突变。
Endocr Pathol. 2020 Mar;31(1):14-20. doi: 10.1007/s12022-020-09607-4.
6
The clinicopathologic characteristics of familial and sporadic papillary thyroid carcinoma in Turkish patients.土耳其患者家族性和散发性甲状腺乳头状癌的临床病理特征。
Turk J Med Sci. 2020 Apr 9;50(2):360-368. doi: 10.3906/sag-1907-94.
7
Identification of Rare Variants Predisposing to Thyroid Cancer.鉴定甲状腺癌易感罕见变异。
Thyroid. 2019 Jul;29(7):946-955. doi: 10.1089/thy.2018.0736. Epub 2019 May 13.
8
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma?家族性疾病是否应被视为微乳头甲状腺癌的一个负预后因素?
J Endocrinol Invest. 2019 Oct;42(10):1205-1213. doi: 10.1007/s40618-019-01039-0. Epub 2019 Mar 29.
9
Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.家族性非髓样甲状腺癌患者的疾病是否更具侵袭性?对初始手术治疗的影响。
Surgery. 2019 Jan;165(1):50-57. doi: 10.1016/j.surg.2018.05.075. Epub 2018 Oct 14.
10
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.全外显子组和靶向测序鉴定 MAP2K5 为家族性非髓样甲状腺癌的新易感基因。
Int J Cancer. 2019 Mar 15;144(6):1321-1330. doi: 10.1002/ijc.31825. Epub 2018 Sep 24.